Related Experiment Video
Updated: Jan 18, 2026

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
Intracellular lymphocyte protein biomarkers for early radiological triage in the human population
Leah Nemzow1, Alec Aljian1, Thomas Boehringer1
1Center for Radiological Research, Columbia University Irving Medical Center, New York, New York, United States of America.
Abstract:
In the event of a large-scale radiological or nuclear emergency, a rapid, high-throughput screening tool will be essential for efficient triage of potentially exposed individuals, optimizing scarce medical resources and ensuring timely care. The objective of this work was to characterize the effects of age and sex on two intracellular lymphocyte protein biomarkers, BAX and p53, for early radiation exposure classification in the human population, using an imaging flow cytometry-based platform for rapid biomarker quantification in whole blood samples. Peripheral blood samples from male and female donors, across three adult age groups (young adult, middle-aged, senior) and a juvenile cohort, were X-irradiated (0-5 Gy), and biomarker expression was quantified at two- and three-days post-exposure. Mixed-effects modeling and ensemble machine learning approaches were employed to evaluate the influence of Age and Sex on biomarker expression and develop predictive models for radiation exposure classification. Although some Age and Sex effects on biomarker expression levels were observed when the data was stratified by targeted conditions of biomarker, day, age group, and sex, these variables were ultimately not retained as significant predictors of exposure classification. A single ensemble model successfully classified radiation exposure across all tested cohorts, with ROC AUC values ranging from 0.85 to 0.95 at the 1 Gy threshold and 0.81 to 0.87 at the 2 Gy threshold, high sensitivity values (91-96%) and low false-negative rates across all classifications. These findings support the use of BAX and p53 biomarkers in a blood test for efficient triage in large-scale emergencies, excluding individuals below exposure thresholds from unnecessary medical care with minimal risk of denying care to those truly exposed.
More Related Videos
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021